Nairametrics
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Industries
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Nairalytics
    • Macro-Economic News
    • Research Analysis
    • Budget
    • Public Debt
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
No Result
View All Result
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Industries
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Nairalytics
    • Macro-Economic News
    • Research Analysis
    • Budget
    • Public Debt
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
No Result
View All Result
Nairametrics
No Result
View All Result
Home Business News Coronavirus

COVID-19: Moderna set to launch a new vaccine for virus strain found in South Africa

Samuel OyekanmibySamuel Oyekanmi
2 years ago
in Coronavirus, Spotlight
Moderna COVID-19 vaccine passes safety test on animals
Share on FacebookShare on TwitterShare on Linkedin

American biotechnology firm, Moderna Inc. on Monday announced that it is launching a trial of a new Covid-19 vaccine as it warned that its current shot was less effective in tackling the strain that emerged in South Africa.

Moderna said it is accelerating work on a covid booster shot to guard against the recently discovered variant in South Africa.

According to the company, Laboratory tests show Moderna’s Covid-19 jab still works against the variant named 501Y.V2, which emerged in South Africa, and B.1.1.7, which was first discovered in the UK.

It however warned that the neutralising antibody response to 501Y.V2 was sixfold lower compared to the original variant, raising concerns that immunity to it may wane significantly, particularly in older people.

“Out of an abundance of caution and leveraging the flexibility of our mRNA platform, we are advancing an emerging variant booster candidate against the variant first identified in the Republic of South Africa into the clinic to determine if it will be more effective to boost titers against this and potentially future variants,” Moderna CEO Stephane Bancel said.

What you should know

  • On Thursday, Dr. Anthony Fauci, White House health advisor said that new data had shown that the Covid-19 vaccines currently on the market may not be as effective against new and more contagious strains of the coronavirus.
  • Also, a team of researchers working with South Africa’s National Institute for Communicable Diseases stated that the 501Y.V2 shows substantial or complete escape from neutralising antibodies in COVID-19 convalescent plasma.
  • According to reports by South African researchers, the 501Y.V2 variant is 50% more infectious than previous ones. It has already spread to at least 20 countries since being reported by the World Health Organisation in late December.
  • Meanwhile, the total confirmed cases of the virus is currently at 99.85 million with over 2 million deaths worldwide.

Related

Tags: CoronavirusCovid-19Modernapandemicsecond wave

Leave a Reply Cancel reply

HFM
Mega Millions
Mega Millions
Patricia





NM newsletters

Business News | Stock Market | Money Market | Cryptos | Financial Literacy | SME |

Recent News

  • Dupe Olusola: The Leader Who Has Attested that Success Isn’t the Result; It’s The Impact!
  • Tony Elumelu Brands Himself in these 5 effective ways
  • Nigeria’s problem is growth, not debt, revenue – Dr. Andrew Nevin

Follow us on social media:

Recent News

The Leader Who Has Attested that Success Isn’t the Result; It’s The Impact!

Dupe Olusola: The Leader Who Has Attested that Success Isn’t the Result; It’s The Impact!

February 5, 2023
Tony Elumelu

Tony Elumelu Brands Himself in these 5 effective ways

February 5, 2023
  • Home
  • Exclusives
  • Markets
  • Industries
  • Economy
  • Business News
  • Financial Literacy
  • Lifestyle
  • Opinions

© 2023 Nairametrics

No Result
View All Result
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Industries
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Nairalytics
    • Macro-Economic News
    • Research Analysis
    • Budget
    • Public Debt
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds

© 2023 Nairametrics